| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 194 |
| 1 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 63 |
| 2 | ALPROSTADIL | 47 |
| 3 | OLANZAPINE | 36 |
| 4 | TADALAFIL | 36 |
| 5 | RISPERIDONE | 34 |
| 6 | QUETIAPINE | 28 |
| 7 | FINASTERIDE | 23 |
| 8 | SERTRALINE | 17 |
| 9 | LISINOPRIL | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALPROSTADIL | 47 | 0.0130 |
| 1 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 63 | 0.0116 |
| 2 | SETMELANOTIDE | 3 | 0.0105 |
| 3 | NYSTATIN AND TRIAMCINOLONE ACETONIDE | 1 | 0.0095 |
| 4 | NYSTATIN, TRIAMCINOLONE ACETONIDE | 1 | 0.0092 |
| 5 | FLURAZEPAM HYDROCHLORIDE | 2 | 0.0049 |
| 6 | BREMELANOTIDE | 3 | 0.0026 |
| 7 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 2 | 0.0019 |
| 8 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 9 | SILDENAFIL CITRATE | 194 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 78 |
| 1 | Prostaglandin Analog [EPC] | 49 |
| 2 | Prostaglandin E1 Agonist [EPC] | 47 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 41 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 5 | Benzodiazepine [EPC] | 30 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 25 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 9 | Anti-epileptic Agent [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 3 | 0.0105 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 4 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 5 | Prostaglandin Analog [EPC] | 49 | 0.0005 |
| 6 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 9 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |